The group of Shippy indicated that one of the ketone bodies, β-hydroxybutyrate (BHB), in a mice model of AD inhibited NLRP3 inflammasome activation and attenuated AD pathology by reduced Asc speck formation, plaque nucleation, and inflammation [156]. The gene discussed is PYCARD; the disease is Alzheimer disease.